Company Information

Celltrion USA

Member Type

Associate

Organization Type

Manufacturer

Description

Celltrion is Korea's leading biologics company dedicated to research, development, and manufacture of biosimilars, new biopharmaceutical products, and small molecule pharmaceutical products with a commitment of contributing to the promotion of human health and social welfare. Equipped with state-of-the-art technology and a spirit of innovation, we succeeded in developing the world's first mAb biosimilar, bringing about a paradigm shift of the entire biopharmaceutical market, where Celltrion now stands at the forefront. Currently, as a global pharmaceutical company, Celltrion acquired Sales Permits in more than 90 countries and actively engaging with 38 Global Marketing Partners. Celltrion achieved what was thought impossible by launching the world’s first ‘antibody biosimilar’. Now Celltrion aims to become a global pharmaceutical company that promotes human health and social welfare for all by developing next-generation biopharmaceutical and small molecule pharmaceutical products. Celltrion Pharm located in Cheongju, Republic of Korea is an FDA cGMP manufacturing approved facility capable of manufacturing 10 billion tablets per year. It is this facility that will be a primary manufacturing location for supporting the Celltrion USA Gx/Bx portfolio for the US market. Celltrion USA, Inc. Product Portfolio - Gx/Bx Solid Dose (current) - Gx Specialty/Injectable (current) - Biosimilar (future) http://www.celltrion.com/en

Contact Information

One Evertrust Plaze, Suite 1207

Jersey City, NJ 07302

http://www.celltrion.com/

Services Offered

Generic

Staff

Start a New Company Search